Enliven Therapeutics Statistics
NASDAQ: ELVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
40.63-0.73 (-1.76%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 41.00 +0.91%
Enliven Therapeutics by the numbers
Enliven Therapeutics has a market capitalization of $2.98 billion based on 73.27M shares outstanding. With trailing EPS of $-1.67, Enliven Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.4% below its 50-day average and 0.5% below its 200-day average.
Average daily trading volume is 1.12M shares, or about $45.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ELVN valuation vs. peer median
| Metric | ELVN | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.98B | $3.07B | -3% |
| Avg. volume | 1.12M | 2.04M | -45% |
Peer median across 8 companies: DYN, RCUS, ARQT, ZLAB, ACAD, MRVI, AMLX, PBLS.
Valuation
- Market cap
- $2.98B
- EPS (TTM)
- $-1.67
- Shares outstanding
- 73.27M
Price and trading
- Previous close
- 41.36
- Open
- 40.90
- Day range
- 39.25 – 40.90
- 52-week range
- 14.79 – 62.32
- 52-week change
- +99.95%
- Beta
- —
- Volume
- 1.65M
- Average volume
- 1.12M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 2.98B
- Forward Pe
- -17.26
- Eps
- -1.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 62.32
- Week52 Low
- 14.79
- Avg Volume
- 1.12M
- Shares Outstanding
- 73.27M
- Ma50
- 54.50
- Ma200
- 40.81
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -34.80%
- Pct From52w Low
- 174.81%